Rubric Capital Management LP

Institutional investor · Portfolio as of Q2 2026

Q2 2026 biggest moves
  • FLRFLR

    Fluor

    New

    2.4% of stocks

  • AMZNAMZN

    Amazon.com

    New

    2.0% of stocks

  • CEGCEG

    Constellation Energy

    Sold out

    was 2.4% of stocks

  • GILGIL

    Gildan Activewear

    3.2× the shares

    now 2.1% of stocks

76 changes in all

Top Holdings87 positions

Checking export access…
Activity:
TLN

Talen Energy Corporation

3.6M$1.4B12.7%$178.24+115.59%
8 qtrssince 2024-Q3
Unchanged
0
FTAI

FTAI Aviation Ltd.

3M$811.6M7.4%$139.46+93.07%
6 qtrssince 2025-Q1
Increased
71
VTRS

Viatris Inc.

34.2M$542.6M5.0%$10.97+43.71%
5 qtrssince 2025-Q2
Increased
59
TEVA
TEVA
ADR

Teva Pharmaceutical Industries Limited

15.6M$527.7M4.8%$11.52+243.86%
14 qtrssince 2023-Q1
Increased
59
GLNG

Golar LNG Limited

9.2M$457.5M4.2%$19.70+151.79%
21 qtrssince 2021-Q2
Unchanged
0
VST

Vistra Corp.

1.8M$284.7M2.6%$160.25-1.17%
3 qtrssince 2025-Q4
Increased
63
TAC

TransAlta Corporation

20.2M$279.8M2.6%$10.68+28.93%
22 qtrssince 2021-Q1
Increased
60
FLR

Fluor Corporation

5M$262.9M2.4%$52.390.00%
1 qtr
New
80
KNSA

Kiniksa Pharmaceuticals International, plc

4M$255.8M2.3%$23.49+172.27%
17 qtrssince 2022-Q2
Increased
56
BGC

BGC Group, Inc.

23.8M$254.4M2.3%$6.40+66.66%
12 qtrssince 2023-Q3
Increased
54
ZM

Zoom Communications, Inc.

2.8M$238.7M2.2%——
2 qtrssince 2026-Q1
Increased
85
GIL

Gildan Activewear, Inc.

4.5M$232.2M2.1%$52.83-2.76%
4 qtrssince 2025-Q3
Increased
85
ARQT

Arcutis Biotherapeutics, Inc.

8.3M$216.9M2.0%$10.16+158.19%
17 qtrssince 2022-Q2
Unchanged
0
AMZN

Amazon.com, Inc.

900,000$214.5M2.0%$238.34+4.54%
1 qtr
New
70
ROIV

Roivant Sciences Ltd.

6M$212.3M1.9%$14.88+137.81%
15 qtrssince 2022-Q4
Increased
57
ZYME

Zymeworks Inc.

7M$183M1.7%——
15 qtrssince 2022-Q4
Unchanged
0
AMCR

Amcor plc

4.2M$180.4M1.7%$41.46+3.08%
2 qtrssince 2026-Q1
Increased
77
CMPR

Cimpress plc

1.8M$178M1.6%$61.85+64.43%
5 qtrssince 2025-Q2
Increased
52
AMRX

Amneal Pharmaceuticals, Inc.

10.2M$176M1.6%$5.62+208.15%
13 qtrssince 2023-Q2
Decreased
0
NRIX

Nurix Therapeutics, Inc.

7.2M$175.3M1.6%$22.45+8.07%
3 qtrssince 2025-Q4
Increased
77
$10.9B
AUM
87
Positions
Q2 2026
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$5,580,219,427-28.3863842317%
2025-Q2$6,619,896,19218.6314674289%
2025-Q3$8,862,850,12633.8820106682%
2025-Q4$8,361,760,336-5.65382222283%
2026-Q1$9,440,073,14812.8957631966%
2026-Q2$10,900,839,42315.4740991102%
Activity profile
$ moved · Q2'26
New18%Increased42%Decreased4%Exited36%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.2 years
<1Q16%1-4Q20%1-2Y6%2Y+59%

Rubric Capital Management LP manages $10.9B across 87 positions as of Q2 2026. Top holdings: TLN (12.7%), FTAI (7.4%), VTRS (5.0%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$11B
TLN12.70%
FTAI7.45%
VTRS4.98%
TEVA4.84%
GLNG4.20%
VST2.61%
TAC2.57%
FLR2.41%
KNSA2.35%
BGC2.33%
Other2.19%

Portfolio allocation by GICS sector

Sectors11
Healthcare33.22%
Utilities18.57%
Industrials14.57%
Consumer Cyclical7.39%
Energy6.02%
Financial Services5.81%
Technology4.16%
Communication Services4.15%
Consumer Defensive3.66%
Real Estate1.23%
Other1.22%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Healthcare, Utilities, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L34
Conviction64
Concentration69
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
GEOGEOThe Geo Group Inc
Q2 2025 → Q3 2026+4.5M shares+$138.3M
5Q
BGCBGCBGC Group, Inc.
Q3 2025 → Q3 2026+9.3M shares+$129.2M
5Q
VTRSVTRSViatris Inc.
Q3 2025 → Q3 2026+24M shares+$530.8M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used